LIVE

REX

REX American Resources Corporation

REX

NYSE·Basic Materials·Chemicals - Specialty·Mkt cap $1.5B

$44.98

-1.14%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$24.88 - $53.36

P/E

16.01

Fwd P/E

29.99

Beta

0.61

Div Yield

0.00%

Avg Vol

211.5K

Shares Out

32.9M

Mkt Cap

$1.5B

Price action

Price chart

Up 77.0% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Integrated corn processing platform maximizing feedstock utilization and margin capture
  • Established distribution network and long-term customer relationships in renewable fuels and livestock sectors
  • Operational efficiency through co-product optimization and energy cost management
  • Strategic positioning in renewable fuels market supported by federal mandates and sustainability trends

Bear Case

2 risks

  • Low volatility (beta 0.6).
  • Significant premium - growth priced in

Growth

Moderate growth ahead

Increasing global demand for renewable fuels and ethanol blending mandates

Value

Significant premium - growth priced in

Momentum

Stable

+0.2% over 3m

Quality

Thin

Excellent business quality

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 26, 2026

Q2 26 RECAP

MAY 28, 2026

Reported EPS of $0.56 vs $0.14 consensus (+290.2% surprise). Revenue of $156.5M vs $167.2M expected (-6.4%).

EPS beat +290.2%
Revenue miss

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+290.2%

Next: Aug 26, 2026

Revenue trend · last 8Q

-16%

-2%

+7%

+0%

-0%

-1%

Q2 24

Q3 24

Q4 25

Q1 25

Q2 25

Q3 25

Q4 26

Q1 26

$148.2M

$174.9M

$158.2M

$158.3M

$158.6M

$175.6M

$158.0M

$156.5M

Margins · last 8Q

Gross

Operating

Profit

11.8%

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

No analyst coverage on file for this stock yet.

vs Industry

How REX stacks vs Chemicals - Specialty

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.